Study design
intracerebral hemorrhage, acute ischemic stroke, seizures
INTRACEREBRAL HEMORRHAGE
Study BIA‐2093‐213 is a Phase II, multicenter, double‐blind, randomized, placebo‐controlled, parallel‐group study in patients at high risk of developing unprovoked seizures after acute intracerebral hemorrhage or an acute ischemic stroke (Figure Study design. EDV, early discontinuation visit; EoT, end of trial visit; ESL, eslicarbazepine acetate; R, randomization; UNS, unscheduled visit; V, visit.